---
title: 'Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver
  transplantation: Potentially modifiable risk factors with major clinical impact'
date: '2024-03-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38554051/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240331180428&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Muscle-wasting and disease-related malnutrition are highly prevalent
  in patients with chronic liver diseases (CLD) as well as in liver transplant (LT)
  candidates. Alterations of body composition (BC) such as sarcopenia, myosteatosis
  and sarcopenic obesity and associated clinical frailty were tied to inferior clinical
  outcomes including hospital admissions, length of stay, complications, mortality
  and healthcare costs in various patient cohorts and clinical scenarios. In contrast
  to ...
disable_comments: true
---
Muscle-wasting and disease-related malnutrition are highly prevalent in patients with chronic liver diseases (CLD) as well as in liver transplant (LT) candidates. Alterations of body composition (BC) such as sarcopenia, myosteatosis and sarcopenic obesity and associated clinical frailty were tied to inferior clinical outcomes including hospital admissions, length of stay, complications, mortality and healthcare costs in various patient cohorts and clinical scenarios. In contrast to ...